We found that transitory depletion of the majority of atypical B cells as well as CD19+IgM+IgD+ cells [which include classical regulatory B cells (38)] immediately prior to and during 4X infection by anti-CD20 mAb administration failed to reverse infection-induced resistance to ECM. This evidence concerns the gene CD19 and infection.